{"id":8951,"date":"2021-04-12T10:36:07","date_gmt":"2021-04-12T17:36:07","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=8951"},"modified":"2021-04-13T10:36:47","modified_gmt":"2021-04-13T17:36:47","slug":"early-evidence-of-covid-19-vaccine-effectiveness-within-the-general-population-of-california","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/12\/early-evidence-of-covid-19-vaccine-effectiveness-within-the-general-population-of-california\/","title":{"rendered":"Early Evidence of COVID-19 Vaccine Effectiveness within the General Population of California"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><i><span style=\"font-weight: 400\">[Pre-print, not peer-reviewed]<\/span><\/i><span style=\"font-weight: 400\"> Fully immunized individuals (either Pfizer-BioNTech or Moderna) experienced 86% protection against SARS-CoV-2 infection, and partial protection was observed following the first dose (66%) and in the first two weeks after receipt of a second dose (78%) in a case-control study conducted from February 24 to April 7, 2021. Cases were defined by a positive SARS-CoV-2 test and controls by a negative test. Among cases <\/span><span style=\"font-weight: 400\">(n = 325), 23 (7%) and 13 (4%) received the Pfizer-BioNTech and Moderna vaccines, respectively, and<\/span><span style=\"font-weight: 400\"> 8 (2%) were fully vaccinated<\/span><span style=\"font-weight: 400\"> while among controls 49 (19%) and 49 (19%) received Pfizer-BioNTech and Moderna, respectively; 42 (16%) were fully vaccinated.<\/span><span style=\"font-weight: 400\"> Hesitancy to receive COVID-19 vaccines (when eligible) was reported among 39% and 23% of unvaccinated participants residing in rural and urban regions, respectively.\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Andrejko et al.\u00a0(Apr 10, 2021). Early Evidence of COVID-19 Vaccine Effectiveness within the General Population of California. Pre-print downloaded Apr 12 from <\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2021.04.08.21255135\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1101\/2021.04.08.21255135<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Pre-print, not peer-reviewed] Fully immunized individuals (either Pfizer-BioNTech or Moderna) experienced 86% protection against SARS-CoV-2 infection, and partial protection was observed following the first dose (66%) and in the first two weeks after receipt of a second dose (78%) in a case-control study conducted from February 24 to April 7, 2021. Cases were defined by&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/12\/early-evidence-of-covid-19-vaccine-effectiveness-within-the-general-population-of-california\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[142],"topic":[31],"class_list":["post-8951","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-vaccine","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=8951"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8951\/revisions"}],"predecessor-version":[{"id":8952,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8951\/revisions\/8952"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=8951"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=8951"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=8951"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=8951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}